Vor Biopharma Inc is a clinical stage cell therapy company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
VOR is expected to report earnings to fall 23.08% to -20 cents per share on August 07
Q2'25
Est.
$-0.20
Q1'25
Missed
by $0.01
Q4'24
Missed
by $0.10
Q3'24
Est.
$-0.40
Q2'24
Beat
by $0.01
The last earnings report on May 29 showed earnings per share of -25 cents, missing the estimate of -25 cents. With 609.88K shares outstanding, the current market capitalization sits at 27.97M.